Key facts
- Lexington Medical’s last known valuation is $283.0M (Apr 2025).
- It has raised $81.5M across 1 recorded rounds; the latest was Early Stage VC ($37.8M) in Apr 2025.
- Notable investors include LSG Holdings, Ampersand Capital Partners, BAMCAP, Norwich Ventures.
- Lexington Medical has filed 1 Form D with the SEC, most recently Apr 2025 ($37.8M sold to 35 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Lexington Medical
Funding rounds
1 roundsAbout Lexington Medical
Manufacturer of surgical instruments intended for health care providers across the United States. The company's instrument offers hemostatic stapling across the skin during surgeries and simplifies procedures such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy, enabling surgeons to perform operations efficiently for reliable output.
- Sector
- Healthcare
- HQ
- Bedford, MA, United States
- Founded
- 2013
- Employees
- 150
- Website
- lexington-med.com/
- Ownership
- Privately Held (backing)
Lexington Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lexington Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lexington Medical in its N-PORT filings yet. We sweep new filings monthly.